Literature DB >> 25914020

Profibrotic transforming growth factor beta 1 and activin A are increased in nasal polyp tissue and induced in nasal polyp epithelium by cigarette smoke and Toll-like receptor 3 ligation.

Moshe Yamin1, Eric H Holbrook2, Stacey T Gray2, Nicolas Y Busaba2, Brooke Lovett1, Daniel L Hamilos1.   

Abstract

BACKGROUND: The mechanism of airway remodeling in chronic rhinosinusitis with nasal polyposis (CRSwNP) remains unknown. We wished to determine whether profibrotic transforming growth factor beta 1 (TGF-β1) and activin A and their downstream signaling proteins are increased in CRSwNP and if they are regulated in epithelial cells by noxious or inflammatory stimuli.
METHODS: Frozen tissue from CRSwNP patients, healthy control (HC) middle turbinates, and sinus tissue from CRS without NP (CRSsNP) patients were immunostained for TGF-β1, activin A, and downstream signaling proteins. Primary nasal epithelial cells (PNECs) from HCs and CRSwNP patients were cultured in media, cigarette smoke extract (CSE), or double-stranded RNA (dsRNA) (a ligand for Toll-like receptor-3) and examined for inflammatory and profibrotic genes using real-time polymerase chain reaction (PCR).
RESULTS: CRSwNP patients showed increased TGF-β1 and activin A in the stroma, increased TGF-β1 signaling (phosphorylated Smad2/3) in the stroma and epithelium, and increased Smad3-dependent Snail1 in the stroma. Immunostaining for TGF-β1, pSmad2/3, and Snail1 in CRSwNP patients was highly correlated. Immunostaining for pSmad2/3 and Snail1 was similar in CRSwNP and CRSsNP patients. Compared to HCs, PNECs from CRSwNP patients were more responsive to CSE and dsRNA in terms of TGF-β1 and activin A and more strongly induced by dsRNA in terms of chemokines.
CONCLUSION: Increased TGF-β1 and activin A and increased downstream TGF-β1 signaling is present in CRSwNP patients, primarily in the stroma. This may contribute to features of airway remodeling previously described. PNECs from CRSwNP patients are induced to produce TGF-β1 and activin A by CSE and dsRNA, suggesting that cigarette smoke and viral infection might also contribute to airway remodeling.
© 2015 ARS-AAOA, LLC.

Entities:  

Keywords:  Activin A; TGF-β1; TLR 3; Toll-like receptor 3; airway remodeling; chronic rhinosinusitis; cigarette smoke; epithelium; inflammation; nasal polyposis; profibrotic; transforming growth factor beta 1

Mesh:

Substances:

Year:  2015        PMID: 25914020     DOI: 10.1002/alr.21516

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  6 in total

1.  Aberrant expression of miR-663 and transforming growth factor-β1 in nasal polyposis in children.

Authors:  Hailing Yu; Jianbao Ju; Jingdong Liu; Da Li
Journal:  Exp Ther Med       Date:  2018-03-06       Impact factor: 2.447

Review 2.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

3.  Roles of TGF-β signaling pathway in endoplasmic reticulum stress in endothelial cells stimulated with cigarette smoke extract.

Authors:  Hong Huang; Qiu-Li Ding; Hui-Fen Zhu; Dao-Feng Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

4.  Expression of Major Lipid Raft Protein Raftlin in Chronic Rhinosinusitis with Nasal Polyps in Smoking and Non-Smoking Patients Correlated with Interleukin-17 and Tumor Necrosis Factor-α Levels.

Authors:  Yu-Tsai Lin; Ming-Hsien Tsai; Yan-Ye Su; Wei-Chih Chen; Shun-Chen Huang; Chih-Yen Chien
Journal:  Biomolecules       Date:  2022-09-17

Review 5.  Airway Epithelial Dynamics in Allergy and Related Chronic Inflammatory Airway Diseases.

Authors:  Anu Laulajainen-Hongisto; Sanna Katriina Toppila-Salmi; Annika Luukkainen; Robert Kern
Journal:  Front Cell Dev Biol       Date:  2020-03-27

6.  DNMTs Are Involved in TGF-β1-Induced Epithelial-Mesenchymal Transitions in Airway Epithelial Cells.

Authors:  Joo-Hoo Park; Jae-Min Shin; Hyun-Woo Yang; Il-Ho Park
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.